May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Interaction of Opticin with 4ß1 and Vß3 Integrins
Author Affiliations & Notes
  • M.M. Le Goff
    Research Group in Eye & Vision Science, University of Manchester, Manchester, United Kingdom
  • S.E. Craig
    Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom
  • M.J. Humphries
    Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom
  • P.N. Bishop
    Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom
  • Footnotes
    Commercial Relationships  M.M. Le Goff, None; S.E. Craig, None; M.J. Humphries, None; P.N. Bishop, None.
  • Footnotes
    Support  The Wellcome Trust
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 435. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.M. Le Goff, S.E. Craig, M.J. Humphries, P.N. Bishop; Interaction of Opticin with 4ß1 and Vß3 Integrins . Invest. Ophthalmol. Vis. Sci. 2003;44(13):435.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Opticin is a member of the extracellular matrix small leucine-rich repeat protein (SLRP) family that was initially identified closely related to vitreous collagen fibrils (JBC, 2000, 275: 2123-2129). Opticin is almost exclusively expressed by the eye and in the mouse its expression is confined to the non-pigmented ciliary epithelium. To date, very little is known about its function. The purpose of this study was to investigate the potential interaction of opticin with cellular receptors such as integrins. Methods: Purified recombinant bovine opticin was used to study its interaction with A375-SM melanoma cells by cell spreading assay. The A375-SM human melanoma cells expressed a variety of integrins. As controls, vascular cell adhesion molecule (VCAM) and a 50-kDa fragment of fibronectin were used as ligands. In order to identify the integrins responsible for interactions, anti-functional antibodies raised against various α and ß chains were used as inhibitors during cell spreading assays. Results: The cell spreading assays showed 30-40% of the cells spreading when opticin was coated on the wells at 100 µg/ml. Inhibition assays revealed that the interaction between A375-SM cells and opticin could be blocked by using anti-functional antibodies raised against α4 (HP1/2), αV (17E6), ß1 (mAb13) and ß3 (14D12.D3) chains. Conclusions: These results suggest that opticin is a ligand for the α4ß1 and αVß3 integrins. Therefore, opticin could be a key regulator of physiological and pathological processes within the eye, including angiogenesis within the vitreous cavity.

Keywords: cell adhesions/cell junctions • extracellular matrix • vitreous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×